Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells

28Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We have previously shown that tetraploid cancer cells succumb through a p53-dependent apoptotic pathway when checkpoint kinase 1 (Chk1) is depleted by small interfering RNAs (siRNAs) or inhibited with 7-hydroxystaurosporine (UCN-01). Here, we demonstrate that Chk1 inhibition results in the activating phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK). Depletion of p38 MAPK by transfection with a siRNA targeting the α isoform of p38 MAPK (p38α MAPK) abolishes the phosphorylation of p53 on serines 15 and 46 that is induced by Chk1 knockdown. The siRNA-mediated downregulation and pharmacological inhibition of p38α MAPK (with SB 203580) also reduces cell death induced by Chk1 knockdown or UCN-01. These results underscore the role of p38 MAPK as a pro-apoptotic kinase in the p53-dependant pathway for the therapeutic elimination of polyploidy cells. ©2008 Landes Bioscience.

Cite

CITATION STYLE

APA

Vitale, I., Senovilla, L., Galluzzi, L., Criollo, A., Vivet, S., Castedo, M., & Kroemer, G. (2008). Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells. Cell Cycle, 7(13), 1956–1961. https://doi.org/10.4161/cc.7.13.6073

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free